DNA

Prenetics Announces Second Quarter 2024 Financial Results

Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024Enters U.S. Health Market in October with IM8, a New…

3 months ago

Mass General Hospital researcher Gary Ruvkun honored with 2024 Nobel Prize

Physiology or Medicine Prize award honors discovery of small regulatory RNAsBoston, MA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Media notice:…

3 months ago

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

LAWRENCEVILLE, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development…

3 months ago

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated…

3 months ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of…

3 months ago

Celebrate Excellence: 16 Top Client-Rated Medical Group Technologies Honored at MGMA’s Leaders Conference 2024 Black Book Awards

Black Book Research, recognized for its unbiased, crowdsourced insights into the physician technology and managed services sectors, highlights the 2024…

3 months ago

Charles Dadswell to step down as General Counsel, Illumina initiates search for successor

SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

3 months ago

Poseida Therapeutics Named to Newsweek’s List of the Top 200 America’s Most Loved Workplaces for 2024

Inclusion on list recognizes Poseida for employee sentiment and satisfaction SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq:…

3 months ago

DiaCarta Enters Contract with the VA Health Care System (San Francisco) for VEXAS Syndrome Testing

PLEASANTON, Calif., Oct. 3, 2024 /PRNewswire/ -- DiaCarta, a leading molecular diagnostic company specializing in oncology and infectious disease tests,…

3 months ago

GenoPalate Unveils Major Upgrade with Enhanced Food Index – Revolutionizing Personalized Nutrition

MILWAUKEE, Oct. 3, 2024 /PRNewswire/ -- GenoPalate, the leading US genomic nutrition platform, announces the launch of its significantly upgraded…

3 months ago